Symptoms and Treatment Burden Associated with Cancer Treatment: Results from a Cross-sectional National Survey in the U.S

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2008 Jan 22

PMID 18204940

Citations 154

Authors

David H Henry

Hema N Viswanathan

Eric P Elkin

Shana Traina

Shawn Wade

David Cella

Affiliations

Soon will be listed here.

Abstract

Goals: To examine the prevalence of chemotherapy-or radiotherapy-associated side effects and related treatment burden, and correlates of fatigue and missed work days among cancer patients.

Materials And Methods: A cross-sectional survey was conducted using a dual sampling frame of 63,949 cancer patients (35,751 from an online panel and 28,198 from telephone listings) > or = 18 years receiving chemotherapy and/or radiotherapy at the time of the survey or during the previous 12 months. Data were collected on cancer type, time since diagnosis, treatment side effects, visits, caregiver burden, missed work days, and sociodemographic characteristics. Data are presented only for patients receiving cancer treatment at the time of the survey.

Main Results: Of the 15,532 patients (24%) who responded to the screening questionnaire, 1,572 met the eligibility criteria and 1,569 completed the survey; 814 received chemotherapy and/or radiotherapy at the time of the survey. The most common side effects were fatigue (80%), pain (48%), and nausea/vomiting (48%). Patients spent 4.5 h, on average, per visit to treat side effects. Approximately 43% of the patients were employed; of these, 78% were actively working. Employed patients missed, on average, 18 work days annually for side effect treatment. Females, younger and unemployed patients, and those with higher levels of anxiety and depression experienced more fatigue; patients with a greater number of side effects endured more missed work days.

Conclusions: In addition to the symptomatic experience of side effects, patients reported a considerable time burden for treatment. It is important to consider supportive care strategies that may effectively reduce side effects and their associated treatment burden.

Citing Articles

Lessons learned from an observational study of patients with breast cancer: adaptions for remote implementation.

Salerno E, Harriss C, Andrade D, Peterson L, Marx C, Duncan R Support Care Cancer. 2025; 33(4):266.

PMID: 40067570 PMC: 11897115. DOI: 10.1007/s00520-025-09323-x.

Improving Health-Related Quality of Life in Hepatocellular Carcinoma Patients: Key Methodologies for Assessing Patient Reported Outcomes and Intervention Targets.

Moon A, Kappelman M, Barritt Iv A, Evon D, Sanoff H, Wagner L J Hepatocell Carcinoma. 2025; 12:497-511.

PMID: 40065839 PMC: 11891488. DOI: 10.2147/JHC.S347929.

Do Terminally Ill Cancer Patients' Self-Assessments and Nurses' Assessments Agree on Cancer-Related Fatigue? A Cross-Sectional Study.

Matsuda M, Honma H, Koyama Y, Kashiwagi Y, Hattori M, Matsumoto Y Palliat Med Rep. 2025; 5(1):563-570.

PMID: 40007693 PMC: 11848060. DOI: 10.1089/pmr.2024.0064.

Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial.

Basch E, Schrag D, Jansen J, Henson S, Ginos B, Stover A Nat Med. 2025; .

PMID: 39920394 DOI: 10.1038/s41591-025-03507-y.

Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment.

Mao J, Bryl K, Gillespie E, Green A, Hung T, Baser R NPJ Digit Med. 2025; 8(1):29.

PMID: 39809874 PMC: 11733120. DOI: 10.1038/s41746-024-01387-z.

References

DeRogatis L, Morrow G, Fetting J, Penman D, Piasetsky S, Schmale A . The prevalence of psychiatric disorders among cancer patients. JAMA. 1983; 249(6):751-7. DOI: 10.1001/jama.249.6.751. View

Andrykowski M, Schmidt J, Salsman J, Beacham A, Jacobsen P . Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol. 2005; 23(27):6613-22. PMC: 2562283. DOI: 10.1200/JCO.2005.07.024. View

Cella D, Lai J, Chang C, Peterman A, Slavin M . Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002; 94(2):528-38. DOI: 10.1002/cncr.10245. View

Curt G . Impact of fatigue on quality of life in oncology patients. Semin Hematol. 2000; 37(4 Suppl 6):14-7. DOI: 10.1016/s0037-1963(00)90063-5. View

Patrick D, Gagnon D, Zagari M, Mathijs R, Sweetenham J . Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa. Eur J Cancer. 2003; 39(3):335-45. DOI: 10.1016/s0959-8049(02)00628-7. View

Teunissen S, Wesker W, Kruitwagen C, de Haes H, Voest E, de Graeff A . Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007; 34(1):94-104. DOI: 10.1016/j.jpainsymman.2006.10.015. View

Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W . Progress toward guidelines for the management of fatigue. Oncology (Williston Park). 1999; 12(11A):369-77. View

Prieto J, Blanch J, Atala J, Carreras E, Rovira M, Cirera E . Clinical factors associated with fatigue in haematologic cancer patients receiving stem-cell transplantation. Eur J Cancer. 2005; 42(12):1749-55. DOI: 10.1016/j.ejca.2005.10.005. View

Cella D . The effects of anemia and anemia treatment on the quality of life of people with cancer. Oncology (Williston Park). 2002; 16(9 Suppl 10):125-32. View

10.

Kallich J, Tchekmedyian N, Damiano A, Shi J, Black J, Erder M . Psychological outcomes associated with anemia-related fatigue in cancer patients. Oncology (Williston Park). 2002; 16(9 Suppl 10):117-24. View

11.

Haley W . Family caregivers of elderly patients with cancer: understanding and minimizing the burden of care. J Support Oncol. 2004; 1(4 Suppl 2):25-9. View

12.

Kessler R, Greenberg P, Mickelson K, Meneades L, Wang P . The effects of chronic medical conditions on work loss and work cutback. J Occup Environ Med. 2001; 43(3):218-25. DOI: 10.1097/00043764-200103000-00009. View

13.

Dillon E, Kelly J . The status of cancer fatigue on the Island of Ireland: AIFC professional and interim patient surveys. Oncologist. 2003; 8 Suppl 1:22-6. DOI: 10.1634/theoncologist.8-suppl_1-22. View

14.

Meehan K, Tchekmedyian N, Smith R, Kallich J . Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa. Clin Drug Investig. 2006; 26(10):593-601. DOI: 10.2165/00044011-200626100-00006. View

15.

Skarstein J, Aass N, Fossa S, Skovlund E, Dahl A . Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Psychosom Res. 2000; 49(1):27-34. DOI: 10.1016/s0022-3999(00)00080-5. View

16.

Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S . The prevalence of psychological distress by cancer site. Psychooncology. 2001; 10(1):19-28. DOI: 10.1002/1099-1611(200101/02)10:1<19::aid-pon501>3.0.co;2-6. View

17.

Vogelzang N, Breitbart W, Cella D, Curt G, Groopman J, Horning S . Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol. 1997; 34(3 Suppl 2):4-12. View

18.

Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman A . Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer. 2006; 15(1):39-46. DOI: 10.1007/s00520-006-0091-0. View

19.

Berndt E, Kallich J, McDermott A, Xu X, Lee H, Glaspy J . Reductions in anaemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy. Pharmacoeconomics. 2005; 23(5):505-14. DOI: 10.2165/00019053-200523050-00009. View

20.

Fossa S, Dahl A, Loge J . Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol. 2003; 21(7):1249-54. DOI: 10.1200/JCO.2003.08.163. View